Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Risperdal Consta Reimbursement Is Question Of “When, Not If” – Alkermes

Executive Summary

Alkermes is confident that Risperdal Consta will ultimately be reimbursed by all 50 state Medicaid programs

You may also be interested in...



Alkermes Seeking Partner For Long-Acting Alcoholism Agent Vivitrex

Alkermes is in discussions with potential co-promotion partners for its long-lasting naltrexone injection Vivitrex for the treatment of alcohol addiction

Alkermes Seeking Partner For Long-Acting Alcoholism Agent Vivitrex

Alkermes is in discussions with potential co-promotion partners for its long-lasting naltrexone injection Vivitrex for the treatment of alcohol addiction

Risperdal Consta Medicare Reimbursement Set At 95% Of AWP

Johnson & Johnson's injectable antipsychotic Risperdal Consta (risperidone) will be reimbursed at 95% of AWP effective April 1 under an update to the Medicare Hospital Outpatient Prospective Payment System

Related Content

UsernamePublicRestriction

Register

PS044088

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel